The Lead Episode 36: One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia-The Lead Episode 36 Speaker Information

The Lead Episode 36 Speaker Information

Pdf Summary

In this discussion, the focus is on a study titled "One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia." The authors of the study are Arkles J, Markman T, Trevillian R, Yegya-Raman N, Garg L, Nazarian S, Santangeli P, Garcia F, Callans D, Frankel DS, and Supple G, and it was published in the Heart Rhythm Journal.<br /><br />The contributors to the discussion are William H. Sauer, MD, FHRS, CCDS from Brigham and Women's Hospital, Paul C Zei, MD, PhD, FHRS from Brigham and Womens Hospital, and Esseim Sharma, MD from University Hospitals Cleveland.<br /><br />The article in question explores the outcomes of stereotactic body radiotherapy (SBRT) as a treatment for refractory ventricular tachycardia. Ventricular tachycardia is a rapid heartbeat that originates in the ventricles of the heart. It can be refractory, meaning it does not respond to conventional treatment options.<br /><br />During the discussion, the contributors disclose their potential conflicts of interest. William H. Sauer, MD, FHRS, CCDS, Exim Sharma, MD, and Paul C Zei, MD, PhD, FHRS have various affiliations with organizations such as Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, and Medtronic.<br /><br />Overall, this discussion highlights the study on SBRT as a potential treatment option for refractory ventricular tachycardia. The contributors provide important insights and disclose any potential conflicts of interest related to the topic.

Keywords

One-Year Outcomes

Stereotactic Body Radiotherapy

Refractory Ventricular Tachycardia

Arkles J

Markman T

Trevillian R

Yegya-Raman N

Garg L

Nazarian S

Heart Rhythm Journal